79 related articles for article (PubMed ID: 12183444)
1. Correspondence re: Y. Kiniwa et al., Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma. Cancer Res., 61: 7900-7907, 2001.
Fodor J
Cancer Res; 2002 Aug; 62(16):4836; author reply 4836-7. PubMed ID: 12183444
[No Abstract] [Full Text] [Related]
2. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor-regression antigens in melanoma.
Kawakami Y; Robbins PF; Wang RF; Rosenberg SA
Important Adv Oncol; 1996; ():3-21. PubMed ID: 8791125
[No Abstract] [Full Text] [Related]
4. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight.
Hussein MR
Br J Dermatol; 2005 Jul; 153(1):18-21. PubMed ID: 16029321
[TBL] [Abstract][Full Text] [Related]
5. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Ayyoub M; Rimoldi D; Guillaume P; Romero P; Cerottini JC; Valmori D; Speiser D
Cancer Res; 2003 Sep; 63(17):5601-6. PubMed ID: 14500401
[TBL] [Abstract][Full Text] [Related]
6. Melanoma, vitiligo, and uveitis.
Albert DM
Ophthalmology; 2010 Mar; 117(3):643-4; author reply 644. PubMed ID: 20189042
[No Abstract] [Full Text] [Related]
7. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
[No Abstract] [Full Text] [Related]
8. Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.
Luiten RM; Kueter EW; Mooi W; Gallee MP; Rankin EM; Gerritsen WR; Clift SM; Nooijen WJ; Weder P; van de Kasteele WF; Sein J; van den Berk PC; Nieweg OE; Berns AM; Spits H; de Gast GC
J Clin Oncol; 2005 Dec; 23(35):8978-91. PubMed ID: 16260696
[TBL] [Abstract][Full Text] [Related]
9. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
Höfs T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):244-50. PubMed ID: 6179826
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.
Becker JC; Guldberg P; Zeuthen J; Bröcker EB; Straten PT
J Invest Dermatol; 1999 Dec; 113(6):1033-8. PubMed ID: 10594748
[TBL] [Abstract][Full Text] [Related]
11. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo.
Palermo B; Garbelli S; Mantovani S; Scoccia E; Da Prada GA; Bernabei P; Avanzini MA; Brazzelli V; Borroni G; Giachino C
Eur J Immunol; 2005 Nov; 35(11):3153-62. PubMed ID: 16224813
[TBL] [Abstract][Full Text] [Related]
12. Antimelanoma immunity in vitiligo and melanoma patients.
Juranic ZD; Stanojevic-Bakic N; Zizak Z; Babovic N; Radovic-Kovacevic V; Stanojkovic T; Dzodic R
Neoplasma; 2003; 50(4):305-9. PubMed ID: 12937846
[TBL] [Abstract][Full Text] [Related]
13. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
[TBL] [Abstract][Full Text] [Related]
14. MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
Godet Y; Moreau-Aubry A; Guilloux Y; Vignard V; Khammari A; Dreno B; Jotereau F; Labarriere N
J Exp Med; 2008 Oct; 205(11):2673-82. PubMed ID: 18936238
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
Salio M; Cella M; Vermi W; Facchetti F; Palmowski MJ; Smith CL; Shepherd D; Colonna M; Cerundolo V
Eur J Immunol; 2003 Apr; 33(4):1052-62. PubMed ID: 12672071
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic mechanisms of vitiligo in a patient with Sézary syndrome.
Knol AC; Quéreux G; Marques-Briand S; Pandolfino MC; Khammari A; Guilloux Y; Dreno B
Br J Dermatol; 2005 Dec; 153(6):1207-12. PubMed ID: 16307660
[TBL] [Abstract][Full Text] [Related]
18. Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.
Yasuda M; Mizukami M; Hanagiri T; Shigematsu Y; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(5A):3607-11. PubMed ID: 17094490
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.
Chakraborty NG; Chattopadhyay S; Mehrotra S; Chhabra A; Mukherji B
Hum Immunol; 2004 Aug; 65(8):794-802. PubMed ID: 15336780
[TBL] [Abstract][Full Text] [Related]
20. Detection of antibodies to human melanoma cells in vitiligo and alopecia areata by Western blot analysis.
Hann SK; Koo SW; Kim JB; Park YK
J Dermatol; 1996 Feb; 23(2):100-3. PubMed ID: 8839236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
